Elanco Animal Health, Inc. (ELAN)

32.10
NYSE
Prev Close 32.54
Day Low/High 31.98 / 32.39
52 Wk Low/High 26.72 / 37.49
Exchange NYSE
Shares Outstanding 473.02B
Market Cap 15.39B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Looking to Exploit a Few Pandemic Trends That Will Continue in 2021

Looking to Exploit a Few Pandemic Trends That Will Continue in 2021

The virtual work force, online shopping and a love of pets are not going to go away even after the coronavirus abates.

Elanco Animal Health Might Just Be the Cat's Meow

Elanco Animal Health Might Just Be the Cat's Meow

ELAN appears ready to make an upside move.

A Sagging Drugmaker and Lagging Pet Health Name Both Worth Looks

A Sagging Drugmaker and Lagging Pet Health Name Both Worth Looks

Alexion Pharmaceuticals and Elanco Animal Health have seen their shares go to the dogs of late, but still offer reasons for portfolio consideration.

A Handful of Small Biotechs That Make for Merger Chatter

A Handful of Small Biotechs That Make for Merger Chatter

The names include a veterinary drug concern plus companies with successful drugs on the market.

News Surrounds 3 Small Biotechs, With a Merger Claiming One

News Surrounds 3 Small Biotechs, With a Merger Claiming One

Two companies in pet pharmaceuticals plan to combine, while two other concerns are worth a look based on developments in their respective spaces.

3 Pet Product Stocks Ready to Be Unleashed: Dogness, Elanco and Zoetis

3 Pet Product Stocks Ready to Be Unleashed: Dogness, Elanco and Zoetis

Pets can bring significant profits to companies that cater to this niche market.

Eli Lilly Shares Decline on Tuesday Despite Strong Earnings Release

Eli Lilly Shares Decline on Tuesday Despite Strong Earnings Release

Eli Lilly's excellent earnings weren't excellent enough.

Eli Lilly's Elanco Offload Offers Acquisition Flexibility

Eli Lilly's Elanco Offload Offers Acquisition Flexibility

Eli Lilly's confirmation of acquisition action could make pharmaceuticals an attractive investment space.

Small Biotechs Finally Join in Market Rebound

Small Biotechs Finally Join in Market Rebound

Exelixis Inc. and Aratana Therapeutics in particular surge after posting solid results Thursday.

A Brief Bird's Eye View of Fresh IPO Elanco Animal Health

A Brief Bird's Eye View of Fresh IPO Elanco Animal Health

The limited technical data for the recent Eli Lilly spinoff indicate buyers came in early and appear to be holding.